I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 65 filers reported holding I MAB in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $954,730 | -84.5% | 723,280 | -64.9% | 0.00% | – |
| Q2 2023 | $6,155,336 | -8.6% | 2,058,641 | +5.8% | 0.00% | – |
| Q1 2023 | $6,735,411 | -19.0% | 1,946,651 | -2.2% | 0.00% | – |
| Q4 2022 | $8,320,098 | -8.7% | 1,990,454 | -12.4% | 0.00% | – |
| Q3 2022 | $9,110,000 | -69.4% | 2,271,671 | -13.9% | 0.00% | -100.0% |
| Q2 2022 | $29,806,000 | -46.1% | 2,637,832 | -22.5% | 0.00% | 0.0% |
| Q1 2022 | $55,270,000 | -52.7% | 3,403,271 | +38.1% | 0.00% | -66.7% |
| Q4 2021 | $116,803,000 | -14.9% | 2,464,740 | +30.2% | 0.00% | -25.0% |
| Q3 2021 | $137,193,000 | -8.8% | 1,892,598 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $150,428,000 | +1841.0% | 1,791,872 | +1020.7% | 0.00% | – |
| Q1 2021 | $7,750,000 | +11.8% | 159,884 | +8.8% | 0.00% | – |
| Q4 2020 | $6,929,000 | +6970.4% | 146,955 | +6951.6% | 0.00% | – |
| Q3 2020 | $98,000 | +1300.0% | 2,084 | +309.4% | 0.00% | – |
| Q1 2020 | $7,000 | – | 509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sage Partners Ltd | 2,054 | $23,000 | 100.00% |
| Cederberg Capital Ltd | 2,215,385 | $25,034,000 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,232 | $553,000,000 | 5.77% |
| IvyRock Asset Management (HK) Ltd | 613,356 | $6,931,000 | 4.38% |
| Zeal Asset Management Ltd | 194,538 | $2,060,000 | 4.25% |
| EDBI Pte Ltd | 222,136 | $2,510,000 | 2.33% |
| HHLR ADVISORS, LTD. | 7,182,850 | $81,166,000 | 1.74% |
| Old Well Partners, LLC | 125,325 | $1,416,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 3,324,000 | $37,561,000 | 0.66% |
| Maso Capital Partners Ltd | 100,000 | $1,130,000 | 0.64% |